Patent ID: 6069175
Filing Date: 2000-05-30
Classification: A61K,A61P

Abstract:
A method of treating atherosclerosis in a nonhyperlipidemic mammal having algerogenic lesions comprising: administering to a mammal in need thereof, a therapeutically effective amount of a member selected from the group consisting of 4-hydroxy tamoxifen, raloxifene, toremifene, centchroman, idoxifene, 6-(4-hydroxy-phenyl)-5-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-naphthalen -2-ol or {4-[2-(2-aza-bicyclo[2.2.1]hept-2-yl)-ethoxy]-phenyl}-[6-hydroxy-2-(4-hydr oxy-phenyl)-benzo[b]thiophen-3-yl]-methanone, or the pharmaceutically acceptable salts thereof, and combinations thereof.